Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

APVOAptevo Therapeutics Inc.

Nasdaq · CIK 0001671584
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts335

Identity from submissions API

NameAptevo Therapeutics Inc.
CIK0001671584
TickersAPVO
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN811567056
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone206-838-0500
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
2401 4TH AVE.
SUITE 1050
SEATTLE
WA
98121
WA
Mailing address
2401 4TH AVE.
SUITE 1050
SEATTLE
WA
98121
WA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

748 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 S-1 S-1 0001193125-26-470268 333-300184 261579389 33 1861633 1 1
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001649553-26-000140 005-89584 261558808 34 11586
2026-11-16 10-Q 10-Q 0001193125-26-462265 001-37746 261555772 34 8314040 1 1
2026-11-16 8-K 8-K 2.02,9.01 0001193125-26-462254 001-37746 261555725 34 204281 1 1
2026-11-12 PRE 14A PRE 14A 0001193125-26-458711 001-37746 261549585 34 2826579
2026-11-12 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-26-458751 001-37746 261548203 34 642323 1 1
2026-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493152-26-051277 005-89584 261544687 34 11833
2026-11-09 8-K 8-K 8.01,9.01 0001193125-26-452737 001-37746 261534006 34 194371 1 1
2026-11-05 8-K 8-K 8.01,9.01 0001193125-26-448714 001-37746 261525019 34 199325 1 1
2026-11-02 8-K 8-K 8.01,9.01 0001193125-26-442031 001-37746 261509386 34 215035 1 1
2026-10-30 424B5 424B5 0001193125-26-441770 333-284969 261508544 33 28756
2026-10-26 8-K 8-K 8.01,9.01 0001193125-26-431079 001-37746 261483594 34 186443 1 1
2026-10-23 8-K 8-K 1.01,3.03,9.01 0001193125-26-430419 001-37746 261482202 34 202149 1 1
2026-10-14 8-K 8-K 8.01,9.01 0001193125-26-421076 001-37746 261458391 34 174144 1 1
2026-09-25 S-8 S-8 0001193125-26-402813 333-299137 261410381 33 416168 1 1
2026-09-24 8-K 8-K 8.01,9.01 0001193125-26-400213 001-37746 261402196 34 172037 1 1
2026-09-23 8-K 8-K 5.07 0001193125-26-399545 001-37746 261401432 34 181403 1 1
2026-09-03 424B4 424B4 0001193125-26-381149 333-298483 261356821 33 802525
2026-09-03 8-K 8-K 8.01,9.01 0001193125-26-381098 001-37746 261356761 34 185863 1 1
2026-09-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002871 333-298483 261356570 33 1744
2026-08-31 DEF 14A DEF 14A 0001193125-26-376763 001-37746 261347785 34 11964058 1 1
2026-08-31 CORRESP filename1.htm 0001193125-26-377083 11153
2026-08-27 UPLOAD filename1.pdf 0000000000-26-008467 333-298483 148242
2026-08-26 D xslFormDX01/primary_doc.xml 06c 0001193125-26-368286 021-595477 261322667 33 12005
2026-08-21 PRE 14A PRE 14A 0001193125-26-361119 001-37746 261304895 34 12710567 1 1
2026-08-21 S-1 S-1 0001193125-26-361103 333-298483 261304800 33 1809660 1 1
2026-08-21 8-K 8-K 5.07 0001193125-26-361079 001-37746 261304683 34 178947 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001649553-26-000098 005-89584 261280077 34 11862
2026-08-14 10-Q 10-Q 0001193125-26-350559 001-37746 261276314 34 10853064 1 1
2026-08-14 8-K 8-K 2.02,9.01 0001193125-26-350537 001-37746 261276296 34 210209 1 1
2026-08-13 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-26-349380 001-37746 261274219 34 1889269 1 1
2026-08-10 4 4 0001193125-26-343080 6821
2026-08-10 4 4 0001193125-26-343079 6895
2026-08-10 4 4 0001193125-26-343077 6951
2026-08-10 4 4 0001193125-26-343076 6923
2026-08-10 4 4 0001193125-26-343073 8413
2026-08-10 4 4 0001193125-26-343072 6831
2026-08-10 4 4 0001193125-26-343070 11976
2026-08-10 4 4 0001193125-26-343069 6834
2026-08-10 4 4 0001193125-26-343067 6836
2026-08-10 4 4 0001193125-26-343065 6832
2026-07-31 DEF 14A DEF 14A 0001193125-26-328604 001-37746 261228701 34 14102510 1 1
2026-07-31 ARS ARS 0001193125-26-328465 001-37746 261228411 34 1868555
2026-07-27 8-K 8-K 8.01,9.01 0001193125-26-318056 001-37746 261205754 34 184098 1 1
2026-07-24 S-8 S-8 0001193125-26-316068 333-297675 261201524 33 433097 1 1
2026-06-30 8-K 8-K 1.01,7.01,9.01 0001193125-26-290473 001-37746 261140484 34 188260 1 1
2026-06-22 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001666270-26-000004 005-89584 261105753 34 7064
2026-06-22 3 PRIMARY DOCUMENT 0001666270-26-000003 4744
2026-05-28 3 3 0001193125-26-245818 11415
2026-05-27 8-K 8-K 1.01,3.02,7.01,9.01 0001193125-26-241867 001-37746 261026101 34 222347 1 1
2026-05-13 10-Q 10-Q 0001193125-26-221661 001-37746 26973486 34 5964636 1 1
2026-05-13 8-K 8-K 2.02,9.01 0001193125-26-221593 001-37746 26973192 34 206528 1 1
2026-05-06 8-K 8-K 8.01,9.01 0001193125-26-208958 001-37746 26948385 34 196770 1 1
2026-03-26 10-K 10-K 0001193125-26-126278 001-37746 26798463 34 13008300 1 1
2026-03-26 8-K 8-K 2.02,9.01 0001193125-26-126190 001-37746 26798052 34 356385 1 1
2026-03-11 8-K 8-K 8.01,9.01 0001193125-26-100539 001-37746 26740804 34 188979 1 1
2026-02-19 8-K 8-K 5.07 0001193125-26-057707 001-37746 26650961 34 171617 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-001127 005-89584 26641980 34 11067
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-26-000020 005-89584 26639885 34 11809
2026-02-03 8-K 8-K 5.02,9.01 0001193125-26-034473 001-37746 26590216 34 217549 1 1
2026-01-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000430 333-293010 26585539 33 1743
2026-01-30 424B4 424B4 0001193125-26-032011 333-293010 26584305 33 399685
2026-01-29 CORRESP filename1.htm 0001193125-26-029443 9920
2026-01-29 UPLOAD filename1.pdf 0000000000-26-001091 333-293010 40059
2026-01-28 S-1 S-1 0001193125-26-027200 333-293010 26572495 33 1387182 1 1
2026-01-26 DEF 14A DEF 14A 0001193125-26-022560 001-37746 26560528 34 1070934 1 1
2026-01-16 PRE 14A PRE 14A 0001193125-26-015339 001-37746 26539468 34 1715377 1 1
2026-01-09 8-K 8-K 1.01,3.02,8.01,9.01 0001193125-26-008318 001-37746 26521392 34 700700 1 1
2025-12-29 8-K 8-K 5.03,9.01 0001193125-25-335497 001-37746 251609992 34 186818 1 1
2025-12-09 8-K 8-K 9.01 0001193125-25-312972 001-37746 251560036 34 214573 1 1
2025-11-25 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003381 333-290663 251523696 33 1744
2025-11-25 424B4 424B4 0001193125-25-297513 333-290663 251522179 33 404144
2025-11-24 CORRESP filename1.htm 0001193125-25-293460 10129
2025-11-12 4 4 0001193125-25-277771 4274
2025-11-07 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000070858-25-000408 005-89584 251461802 34 110663
2025-11-06 10-Q 10-Q 0001193125-25-269598 001-37746 251458561 34 7479379 1 1
2025-11-06 8-K 8-K 2.02,9.01 0001193125-25-269470 001-37746 251458207 34 406187 1 1
2025-10-30 8-K 8-K 1.01,3.03,9.01 0001193125-25-258665 001-37746 251436161 34 195262 1 1
2025-10-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000070858-25-000377 005-89584 251377133 34 110614
2025-10-03 4 PRIMARY DOCUMENT 0000070858-25-000374 10204
2025-10-03 3 PRIMARY DOCUMENT 0000070858-25-000373 12315
2025-10-01 S-1 S-1 0001193125-25-226825 333-290663 251365035 33 1386359 1 1
2025-09-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004113 005-89584 251321084 34 17100
2025-09-16 8-K 8-K 8.01,9.01 0001193125-25-205107 001-37746 251318051 34 209961 1 1
2025-09-04 8-K 8-K 8.01,9.01 0001671584-25-000005 001-37746 251293652 34 203010 1 1
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-25-001313 005-89584 251221755 34 8102
2025-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-25-000151 005-89584 251217282 34 11694
2025-08-13 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001641172-25-023309 005-89584 251208877 34 11693
2025-08-11 10-Q 10-Q 0000950170-25-106247 001-37746 251200287 34 7059840 1 1
2025-08-11 8-K 8-K 2.02,9.01 0000950170-25-106246 001-37746 251200283 34 393306 1 1
2025-08-08 4 4 0000950170-25-105942 5218
2025-08-08 4 4 0000950170-25-105938 5337
2025-08-08 4 4 0000950170-25-105936 5214
2025-08-08 4 4 0000950170-25-105935 5261
2025-08-08 4 4 0000950170-25-105933 5216
2025-08-08 4 4 0000950170-25-105930 5273
2025-08-08 4 4 0000950170-25-105922 5264
2025-08-08 4 4 0000950170-25-105919 5220
2025-08-08 4 4 0000950170-25-105894 5291
2025-08-08 4 4 0000950170-25-105887 5205
2025-08-08 424B4 424B4 0000950170-25-105823 333-288959 251198362 33 401605
2025-08-01 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002457 333-288959 251177853 33 1744
2025-07-31 CORRESP filename1.htm 0000950170-25-100776 11467
2025-07-30 UPLOAD filename1.pdf 0000000000-25-008051 333-288959 40082
2025-07-25 S-1 S-1 0000950170-25-098788 333-288959 251151868 33 1232240
2025-07-24 8-K 8-K 5.07 0000950170-25-098429 001-37746 251147982 34 210992 1 1
2025-07-21 4 4 0000950170-25-097283 6666
2025-07-21 4 4 0000950170-25-097280 6681
2025-07-21 4 4 0000950170-25-097279 6679
2025-07-21 4 4 0000950170-25-097278 6675
2025-07-21 4 4 0000950170-25-097274 6677
2025-07-21 4 4 0000950170-25-097272 6835
2025-07-21 4 4 0000950170-25-097271 6807
2025-07-21 4 4 0000950170-25-097269 6767
2025-07-21 4 4 0000950170-25-097267 6805
2025-07-09 3 3 0000950170-25-094856 18496
2025-07-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-066378 005-89584 251110596 34 20646
2025-07-03 DEF 14A DEF 14A 0000950170-25-093924 001-37746 251107670 34 4475355 1 1
2025-07-03 ARS ARS 0000950170-25-093869 001-37746 251105721 34 4850905
2025-07-01 8-K 8-K 8.01 0000950170-25-092318 001-37746 251097329 34 145180 1 1
2025-06-30 8-K 8-K 8.01 0000950170-25-091581 001-37746 251092218 34 148004 1 1
2025-06-25 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-057838 005-89584 251074105 34 21738
2025-06-25 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-001833 005-89584 251073995 34 18142
2025-06-23 PRE 14A PRE 14A 0000950170-25-089090 001-37746 251066029 34 4420674 1 1
2025-06-23 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-25-001053 005-89584 251065024 34 7831
2025-06-23 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-25-001052 005-89584 251065015 34 7987
2025-06-23 8-K 8-K 4.01,9.01 0000950170-25-088970 001-37746 251064974 34 163158 1 1
2025-06-20 8-K 8-K 8.01,9.01 0000950170-25-088592 001-37746 251062376 34 289858 1 1
2025-06-20 424B5 424B5 0000950170-25-088588 333-284969 251062298 33 26240
2025-06-20 8-K 8-K 1.01,8.01,9.01 0000950170-25-088494 001-37746 251061322 34 1455078 1 1
2025-06-20 424B4 424B4 0000950170-25-088195 333-288061 251059258 33 983701
2025-06-18 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001965 333-288061 251058906 33 1744
2025-06-18 S-1MEF S-1MEF 0000950170-25-087813 333-288134 251056346 33 264143
2025-06-17 8-K 8-K 1.01,3.02,9.01 0000950170-25-087368 001-37746 251053479 34 671982 1 1
2025-06-16 CORRESP filename1.htm 0000950170-25-086571 11746
2025-06-16 S-1 S-1 0000950170-25-086548 333-288061 251048578 33 2765429
2025-06-04 UPLOAD filename1.pdf 0000000000-25-005902 377-08065 40286
2025-05-30 DRS filename1.htm 0000950123-25-005937 377-08065 251012264 33 2536250
2025-05-28 424B3 424B3 0000950170-25-078328 333-287244 25995412 33 989081
2025-05-23 8-K 8-K 5.03,9.01 0000950170-25-077089 001-37746 25983338 34 192389 1 1
2025-05-22 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001715 333-287244 25979104 33 1743
2025-05-22 8-K 8-K 3.01,8.01,9.01 0000950170-25-076482 001-37746 25978368 34 315347 1 1
2025-05-22 424B5 424B5 0000950170-25-076336 333-284969 25977306 33 25704
2025-05-21 CORRESP filename1.htm 0000950170-25-075622 11343
2025-05-20 UPLOAD filename1.pdf 0000000000-25-005388 333-287244 40094
2025-05-15 10-Q 10-Q 0000950170-25-072622 001-37746 25953041 34 6422511 1 1
2025-05-15 8-K 8-K 2.02,9.01 0000950170-25-072594 001-37746 25952728 34 369431 1 1
2025-05-13 S-1 S-1 0000950170-25-070551 333-287244 25941678 33 1755521
2025-05-13 RW RW 0000950170-25-069821 333-286952 25937258 NE 12935
2025-05-13 RW RW 0000950170-25-069820 333-285476 25937256 NE 12992
2025-05-02 S-3 S-3 0000950170-25-062910 333-286952 25909710 33 1356705
2025-04-29 8-K 8-K 8.01,9.01 0000950170-25-060317 001-37746 25889093 34 257258 1 1
2025-04-29 424B5 424B5 0000950170-25-060303 333-284969 25888956 33 25473
2025-04-28 424B4 424B4 0000950170-25-058974 333-284969 25876031 33 1318953
2025-04-28 8-K 8-K 1.01,2.02,8.01,9.01 0000950170-25-058966 001-37746 25875997 34 687801 1 1
2025-04-25 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-035548 005-89584 25873977 34 16356
2025-04-25 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001553350-25-000023 005-89584 25873786 34 7669
2025-04-25 DEF 14A DEF 14A 0000950170-25-058694 001-37746 25873774 34 1614034
2025-04-25 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001553350-25-000022 005-89584 25873633 34 8085
2025-04-22 8-K 8-K 1.01,8.01,9.01 0000950170-25-056736 001-37746 25857892 34 831933 1 1
2025-04-22 424B4 424B4 0000950170-25-056475 333-284969 25855024 33 1977528
2025-04-18 D xslFormDX01/primary_doc.xml 06c 0001671584-25-000001 021-544060 25849666 33 6040
2025-04-10 PRE 14A PRE 14A 0000950170-25-052922 001-37746 25829150 34 882752
2025-04-10 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001649553-25-000060 005-89584 25826860 34 15118
2025-04-09 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001213900-25-030378 005-89584 25826029 34 16911
2025-04-08 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000921895-25-001026 005-89584 25823312 34 17420
2025-04-07 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001079973-25-000599 005-89584 25818787 34 7711
2025-04-04 8-K 8-K 1.01,8.01,9.01 0000950170-25-051143 001-37746 25814953 34 1371167 1 1
2025-04-04 424B4 424B4 0000950170-25-050924 333-284969 25812329 33 2000025
2025-04-01 S-1/A S-1/A 0000950170-25-048016 333-285476 25796523 33 1817057
2025-03-27 S-1/A S-1/A 0000950170-25-046199 333-285476 25780509 33 2040189
2025-03-27 S-1/A S-1/A 0000950170-25-045728 333-285476 25775278 33 2020485
2025-03-25 S-1/A S-1/A 0000950170-25-044078 333-285476 25765733 33 2872092
2025-03-20 8-K 8-K 7.01,8.01,9.01 0000950170-25-042340 001-37746 25754618 34 19772288 1 1
2025-03-04 4 4 0000950170-25-032201 10350
2025-03-04 4 4 0000950170-25-032197 10333
2025-03-04 4 4 0000950170-25-032187 10332
2025-03-04 4 4 0000950170-25-032183 10395
2025-03-03 S-1 S-1 0000950170-25-030286 333-285476 25693590 33 2616651
2025-02-26 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000537 333-284969 25672543 33 1750
2025-02-24 CORRESP filename1.htm 0000950170-25-025930 8925
2025-02-21 UPLOAD filename1.pdf 0000000000-25-002044 333-284969 40094
2025-02-14 S-3 S-3 0000950170-25-021191 333-284969 25628782 33 2668567
2025-02-14 10-K 10-K 0000950170-25-020467 001-37746 25623597 34 14742252 1 1
2025-02-14 8-K 8-K 2.02,9.01 0000950170-25-020465 001-37746 25623581 34 405533 1 1
2025-02-11 8-K 8-K 7.01,9.01 0000950170-25-017473 001-37746 25607792 34 21537971 1 1
2025-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002033916-25-000016 005-89584 25607161 34 10804
2025-02-10 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002033916-25-000004 005-89584 25606041 34 9232
2025-01-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000028 333-283983 25503633 33 1750
2025-01-02 CORRESP filename1.htm 0000950170-25-000095 9681
2024-12-30 UPLOAD filename1.pdf 0000000000-24-014315 333-283983 40078
2024-12-20 S-3 S-3 0000950170-24-139087 333-283983 241568403 33 1497654
2024-12-12 8-K 8-K 1.01,3.02,9.01 0000950170-24-135890 001-37746 241545957 34 525191 1 1
2024-12-12 8-K 8-K 8.01,9.01 0000950170-24-135609 001-37746 241543369 34 200004 1 1
2024-12-04 8-K 8-K 8.01,9.01 0000950170-24-133091 001-37746 241524954 34 195103 1 1
2024-12-03 8-K 8-K 5.03,9.01 0000950170-24-132855 001-37746 241523600 34 193433 1 1
2024-11-26 8-K 8-K 8.01,9.01 0000950170-24-130763 001-37746 241498282 34 191197 1 1
2024-11-22 8-K 8-K 8.01,9.01 0000950170-24-129971 001-37746 241486662 34 205303 1 1
2024-11-20 8-K 8-K 8.01,9.01 0000950170-24-129018 001-37746 241478360 34 199211 1 1
2024-11-14 SC 13G/A armistice-apvo093024a1.htm 0001172661-24-005117 005-89584 241461194 34 90413
2024-11-08 SC 13G APVO 13G 0002033916-24-000031 005-89584 241440052 34 58979
2024-11-07 10-Q 10-Q 0000950170-24-122837 001-37746 241433354 34 7637449 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-122830 001-37746 241433324 34 391519 1 1
2024-11-04 8-K 8-K 1.01,3.03,9.01 0000950170-24-120188 001-37746 241420278 34 198226 1 1
2024-10-25 8-K 8-K 5.07 0000950170-24-117439 001-37746 241397426 34 171915 1 1
2024-10-03 DEF 14A DEF 14A 0000950170-24-112395 001-37746 241352120 34 2561694
2024-09-23 PRE 14A PRE 14A 0000950170-24-108772 001-37746 241316710 34 1575821
2024-09-18 8-K 8-K 1.01,8.01,9.01 0000950170-24-107776 001-37746 241307524 34 2629934 1 1
2024-09-17 424B4 424B4 0000950170-24-107412 333-281892 241305476 33 1215683
2024-09-16 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-09-16 09:00:00 9999999995-24-002853 333-281892 241302418 33 1751
2024-09-16 8-K 8-K 8.01,9.01 0000950170-24-106614 001-37746 241299385 34 203386 1 1
2024-09-11 CORRESP filename1.htm 0000950170-24-105597 12809
2024-09-11 CORRESP filename1.htm 0000950170-24-105596 9967
2024-09-06 UPLOAD filename1.pdf 0000000000-24-010107 333-281892 40023
2024-08-30 S-1 S-1 0000950170-24-102458 333-281892 241271218 33 2658594
2024-08-09 4 4 0000950170-24-094819 6800
2024-08-09 4 4 0000950170-24-094816 10350
2024-08-09 4 4 0000950170-24-094813 6850
2024-08-08 10-Q 10-Q 0000950170-24-093366 001-37746 241186234 34 7009714 1 1
2024-08-08 8-K 8-K 2.02,9.01 0000950170-24-093356 001-37746 241186199 34 386759 1 1
2024-08-07 8-K 8-K 5.07 0000950170-24-092865 001-37746 241184281 34 170988 1 1
2024-07-19 4 4 0000950170-24-084958 5209
2024-07-19 4 4 0000950170-24-084955 5363
2024-07-19 4 4 0000950170-24-084954 5218
2024-07-19 4 4 0000950170-24-084953 5317
2024-07-19 4 4 0000950170-24-084952 5302
2024-07-19 4 4 0000950170-24-084950 5300
2024-07-19 4 4 0000950170-24-084947 5212
2024-07-19 4 4 0000950170-24-084946 5224
2024-07-19 4 4 0000950170-24-084944 5233
2024-07-15 DEF 14A DEF 14A 0000950170-24-083313 001-37746 241115909 34 1555111
2024-07-12 S-8 S-8 0000950170-24-083225 333-280789 241114882 33 155044
2024-07-03 PRE 14A PRE 14A 0000950170-24-081568 001-37746 241100463 34 1552959
2024-07-01 8-K 8-K 3.01 0000950170-24-079672 001-37746 241091074 34 158334 1 1
2024-07-01 8-K 8-K 1.01,8.01,9.01 0000950170-24-079653 001-37746 241090987 34 2352730 1 1
2024-06-28 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-06-28 09:00:00 9999999995-24-002018 333-280226 241087731 33 1751
2024-06-28 424B4 424B4 0000950170-24-079124 333-280226 241086541 33 1186757
2024-06-26 S-1/A S-1/A 0000950170-24-077621 333-280226 241070701 33 1793816
2024-06-25 CORRESP filename1.htm 0000950170-24-077100 9655
2024-06-20 UPLOAD filename1.pdf 0000000000-24-007051 333-280226 40288
2024-06-14 S-1 S-1 0000950170-24-073737 333-280226 241045345 33 2656056
2024-06-10 8-K 8-K 5.07 0000950170-24-071338 001-37746 241033162 34 176427 1 1
2024-06-03 4 4 0000950170-24-068075 10601
2024-06-03 4 4 0000950170-24-068073 10598
2024-06-03 4 4 0000950170-24-068070 10622
2024-06-03 4 4 0000950170-24-068068 10613
2024-06-03 4 4 0000950170-24-068067 10665
2024-06-03 4 4 0000950170-24-068036 7113
2024-05-08 10-Q 10-Q 0000950170-24-055096 001-37746 24924386 34 5895909 1 1
2024-05-08 8-K 8-K 2.02,9.01 0000950170-24-055087 001-37746 24924357 34 334751 1 1
2024-04-23 ARS ARS 0000950170-24-046911 001-37746 24864982 34 2992495
2024-04-23 DEFA14A DEFA14A 0000950170-24-046896 001-37746 24864902 34 655424
2024-04-23 DEF 14A DEF 14A 0000950170-24-046881 001-37746 24864815 34 3398540
2024-04-15 8-K 8-K 1.01,8.01,9.01 0000950170-24-044419 001-37746 24844841 34 1154123 1 1
2024-04-12 424B4 424B4 0000950170-24-044148 333-278103 24842474 33 1153649
2024-04-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-04-10 09:00:00 9999999995-24-000919 333-278103 24837032 33 1750
2024-04-09 S-1/A S-1/A 0000950170-24-043059 333-278103 24833644 33 1696475
2024-04-08 CORRESP filename1.htm 0000950170-24-042692 12818
2024-04-08 CORRESP filename1.htm 0000950170-24-042691 11923
2024-03-29 CORRESP filename1.htm 0000950170-24-038749 26467
2024-03-29 S-1/A S-1/A 0000950170-24-038743 333-278103 24804678 33 1742980
2024-03-29 UPLOAD filename1.pdf 0000000000-24-003386 333-278103 43357
2024-03-20 S-1 S-1 0000950170-24-034178 333-278103 24767983 33 2650563
2024-03-07 8-K 8-K 8.01,9.01 0000950170-24-027613 001-37746 24728285 34 204895 1 1
2024-03-05 8-K 8-K 5.03,9.01 0000950170-24-026223 001-37746 24722049 34 186920 1 1
2024-03-05 4 4 0000950170-24-025921 10393
2024-03-05 4 4 0000950170-24-025915 10331
2024-03-05 4 4 0000950170-24-025881 10366
2024-03-05 4 4 0000950170-24-025878 10332
2024-03-05 10-K 10-K 0000950170-24-025428 001-37746 24718389 34 11844299 1 1
2024-03-05 8-K 8-K 2.02,9.01 0000950170-24-025427 001-37746 24718371 34 340195 1 1
2024-02-14 SC 13G armistice-apvo123123.htm 0001172661-24-001314 005-89584 24636767 34 90401
2024-02-06 8-K 8-K 5.07 0000950170-24-011766 001-37746 24600813 34 168152 1 1
2024-01-30 4 4 0000950170-24-009005 6839
2024-01-30 4 4 0000950170-24-009003 6778
2024-01-30 4 4 0000950170-24-009002 6836
2024-01-30 DEFR14A DEFR14A 0000950170-24-008535 001-37746 24575901 34 38893
2024-01-16 DEFR14A DEFR14A 0000950170-24-004620 001-37746 24535314 34 427804
2023-12-22 DEF 14A DEF 14A 0000950170-23-072644 001-37746 231509943 34 2839372
2023-12-12 PRE 14A PRE 14A 0000950170-23-069702 001-37746 231481467 34 1694087
2023-11-30 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-11-30 17:30:00 9999999995-23-003508 333-275710 231457414 33 1702
2023-11-29 CORRESP filename1.htm 0000950170-23-066620 9298
2023-11-29 UPLOAD filename1.pdf 0000000000-23-012981 40292
2023-11-22 S-3 S-3 0000950170-23-065871 333-275710 231433434 33 707644
2023-11-14 10-Q 10-Q 0000950170-23-063379 001-37746 231401757 34 8021047 1 1
2023-11-14 8-K 8-K 2.02,9.01 0000950170-23-063369 001-37746 231401699 34 470307 1 1
2023-11-09 8-K 8-K 1.01,3.02,9.01 0000950170-23-062234 001-37746 231393792 34 1256693 1 1
2023-11-03 8-K 8-K 1.01,3.03,9.01 0000950170-23-058840 001-37746 231376510 34 209486 1 1
2023-09-15 8-K 8-K 3.01 0000950170-23-048392 001-37746 231259133 34 166157 1 1
2023-08-10 4 FORM 4 SUBMISSION 0001209191-23-045306 7025
2023-08-10 4 FORM 4 SUBMISSION 0001209191-23-045303 7037
2023-08-10 4 FORM 4 SUBMISSION 0001209191-23-045301 7022
2023-08-10 4 FORM 4 SUBMISSION 0001209191-23-045298 7031
2023-08-10 4 FORM 4 SUBMISSION 0001209191-23-045294 7046
2023-08-10 4 FORM 4 SUBMISSION 0001209191-23-045267 7170
2023-08-10 4 FORM 4 SUBMISSION 0001209191-23-045265 7120
2023-08-10 4 FORM 4 SUBMISSION 0001209191-23-045263 10976
2023-08-10 10-Q 10-Q 0000950170-23-040983 001-37746 231157336 34 8056456 1 1
2023-08-10 8-K 8-K 2.02,9.01 0000950170-23-040981 001-37746 231157283 34 546063 1 1
2023-08-07 8-K 8-K 1.01,8.01,9.01 0000950170-23-038673 001-37746 231145282 34 1434252 1 1
2023-08-03 424B4 424B4 0000950170-23-038144 333-273067 231141236 33 531395
2023-08-01 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-08-01 17:30:00 9999999995-23-002244 333-273067 231133546 33 1702
2023-08-01 S-1/A S-1/A 0000950170-23-036437 333-273067 231131548 33 1534719
2023-08-01 CORRESP filename1.htm 0000950170-23-036237 22634
2023-08-01 CORRESP filename1.htm 0000950170-23-036236 12110
2023-07-28 CORRESP filename1.htm 0000950170-23-035319 22623
2023-07-28 CORRESP filename1.htm 0000950170-23-035318 12254
2023-07-26 CORRESP filename1.htm 0000950170-23-034815 23005
2023-07-26 CORRESP filename1.htm 0000950170-23-034762 12108
2023-07-21 CORRESP filename1.htm 0000950170-23-033833 22131
2023-07-21 CORRESP filename1.htm 0000950170-23-033832 12254
2023-07-18 8-K 8-K 8.01,9.01 0000950170-23-033264 001-37746 231093054 34 232563 1 1
2023-07-14 CORRESP filename1.htm 0000950170-23-033011 22655
2023-07-14 CORRESP filename1.htm 0000950170-23-033010 12108
2023-07-14 S-1/A S-1/A 0000950170-23-033000 333-273067 231089310 33 2376476
2023-07-06 UPLOAD filename1.pdf 0000000000-23-007197 40247
2023-06-30 S-1 S-1 0000950170-23-031113 333-273067 231061940 33 1474960
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033846 9313
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033841 9319
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033835 9307
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033830 9328
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033828 9304
2023-06-02 4 FORM 4 SUBMISSION 0001209191-23-033823 7122
2023-06-02 8-K 8-K 5.07 0000950170-23-026092 001-37746 23989252 34 199098 1 1
2023-05-11 10-Q 10-Q 0000950170-23-020870 001-37746 23909012 34 7426924 1 1
2023-05-11 8-K 8-K 2.02,9.01 0000950170-23-020863 001-37746 23908974 34 432467 1 1
2023-04-19 DEFA14A DEFA14A 0000950170-23-013365 001-37746 23828534 34 1368688
2023-04-18 ARS ARS 0000950170-23-013176 001-37746 23825575 34 1667778
2023-04-18 DEF 14A DEF 14A 0000950170-23-013175 001-37746 23825569 34 3322585
2023-03-30 10-K 10-K 0000950170-23-010757 001-37746 23777198 34 11605420 1 1
2023-03-30 8-K 8-K 2.02,7.01,9.01 0000950170-23-010755 001-37746 23777181 34 466484 1 1
2023-03-30 8-K 8-K 1.01,1.02,7.01,9.01 0000950170-23-010752 001-37746 23777167 34 218145 1 1
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016789 11674
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016786 11687
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016783 11736
2023-03-07 4/A FORM 4/A SUBMISSION 0001209191-23-016778 4214
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016774 11680
2023-03-07 3 FORM 3 SUBMISSION 0001209191-23-016753 17910
2023-03-07 8-K 8-K 5.02,9.01 0000950170-23-006384 001-37746 23711091 34 182312 1 1
2023-02-14 SC 13G/A APTEVO THERAPEUTICS INC. 0000902664-23-001735 005-89584 23623932 34 61251
2023-02-13 8-K 8-K 8.01,9.01 0000950170-23-002538 001-37746 23614831 34 251674 1 1
2023-01-30 4 FORM 4 SUBMISSION 0001209191-23-005423 7091
2023-01-30 4 FORM 4 SUBMISSION 0001209191-23-005420 7079
2023-01-09 8-K 8-K 8.01,9.01 0001564590-23-000273 001-37746 23516720 34 187846 1 1
2022-12-12 8-K 8-K 8.01,9.01 0001564590-22-039215 001-37746 221456223 34 213854 1 1
2022-11-10 10-Q 10-Q 0001564590-22-037287 001-37746 221375116 34 8013871 1 1
2022-11-10 8-K 8-K 2.02,9.01 0001564590-22-037285 001-37746 221375071 34 472147 1 1
2022-11-04 8-K 8-K 1.01,3.03,9.01 0001564590-22-036769 001-37746 221362539 34 203173 1 1
2022-09-19 8-K 8-K 8.01,9.01 0000950123-22-009848 001-37746 221249659 34 212779 1 1
2022-08-11 10-Q 10-Q 0001564590-22-029025 001-37746 221153846 34 7538980 1 1
2022-08-11 8-K 8-K 2.02,9.01 0001564590-22-029023 001-37746 221153804 34 477822 1 1
2022-08-10 4 FORM 4 SUBMISSION 0001209191-22-045193 5368
2022-08-10 4 FORM 4 SUBMISSION 0001209191-22-045189 5461
2022-08-10 4 FORM 4 SUBMISSION 0001209191-22-045188 5374
2022-08-10 4 FORM 4 SUBMISSION 0001209191-22-045184 5383
2022-08-10 4 FORM 4 SUBMISSION 0001209191-22-045183 10034
2022-08-10 4 FORM 4 SUBMISSION 0001209191-22-045182 5359
2022-08-10 4 FORM 4 SUBMISSION 0001209191-22-045181 5362
2022-06-09 8-K 8-K 8.01,9.01 0001564590-22-022813 001-37746 221004969 34 218408 1 1
2022-06-08 8-K 8-K 1.01,8.01 0001564590-22-022767 001-37746 221003588 34 165410 1 1
2022-06-07 4 FORM 4 SUBMISSION 0001209191-22-034879 6303
2022-06-07 4 FORM 4 SUBMISSION 0001209191-22-034876 6325
2022-06-07 4 FORM 4 SUBMISSION 0001209191-22-034873 6313
2022-06-07 S-8 S-8 0001564590-22-022706 333-265468 221001889 33 185857
2022-06-07 8-K 8-K 5.07 0001564590-22-022694 001-37746 221001701 34 191803 1 1
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-033936 9792
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-033933 7089
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-033930 10470
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-033928 12454
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-033924 9785
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-033920 9776
2022-05-31 8-K 8-K 8.01 0001564590-22-021764 001-37746 22980653 34 159541 1 1
2022-05-12 10-Q 10-Q 0001564590-22-019685 001-37746 22915846 34 6233094 1 1
2022-05-12 8-K 8-K 2.02,9.01 0001564590-22-019680 001-37746 22915801 34 402608 1 1
2022-04-27 DEF 14A DEF 14A 0001564590-22-015884 001-37746 22856476 34 2394167
2022-04-07 8-K 8-K 3.01 0001564590-22-013856 001-37746 22814148 34 162154 1 1
2022-03-30 8-K/A 8-K/A 8.01,9.01 0001564590-22-012331 001-37746 22783324 34 175693 1 1
2022-03-29 8-K 8-K 8.01,9.01 0001564590-22-012068 001-37746 22777488 34 192690 1 1
2022-03-29 424B5 424B5 0001564590-22-012065 333-251318 22777448 33 32703
2022-03-24 424B5 424B5 0001564590-22-011578 333-251318 22764793 33 32706
2022-03-24 10-K 10-K 0001564590-22-011575 001-37746 22764766 34 10674866 1 1
2022-03-24 8-K 8-K 2.02,7.01,9.01 0001564590-22-011574 001-37746 22764749 34 425349 1 1
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016457 8055
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016453 8068
2022-03-04 4 FORM 4 SUBMISSION 0001209191-22-016448 8070
2022-02-18 8-K 8-K 8.01,9.01 0001564590-22-005709 001-37746 22653256 34 178670 1 1
2022-02-18 424B5 424B5 0001564590-22-005705 333-251318 22652955 33 606982
2022-02-17 8-K 8-K 1.01,9.01 0001564590-22-005567 001-37746 22648293 34 755527 1 1
2022-02-10 SC 13G/A apvo-13g_20211231.txt 0001037389-22-000012 005-89584 22613509 34 13309
2022-02-09 8-K 8-K 8.01,9.01 0001564590-22-004304 001-37746 22603881 34 205550 1 1
2022-02-01 4 xslF345X03/white.xml 0001019056-22-000114 6985
2022-02-01 4 xslF345X03/lamothe.xml 0001019056-22-000112 6983
2022-01-21 8-K APVO-2022-01-21 8K 5.02,7.01,9.01 0001564590-22-001848 001-37746 22544178 34 196310 1 1
2021-12-07 4 xslF345X03/elhibri.xml 0001019056-21-000634 10572
2021-11-26 4 FORM 4 SUBMISSION 0001209191-21-066910 20533
2021-11-26 SC 13D/A AMENDMENT NO. 5 0001214659-21-012287 005-89584 211450966 34 69148
2021-11-23 8-K APVO-2021-11-23 8K 8.01,9.01 0001564590-21-057958 001-37746 211434770 34 198690 1 1
2021-11-22 SC 13D/A AMENDMENT NO. 4 0001214659-21-012163 005-89584 211433744 34 72838
2021-11-22 4 FORM 4 SUBMISSION 0001209191-21-066146 26245
2021-11-12 8-K 8-K 2.02,9.01 0001564590-21-056501 001-37746 211399839 34 467362 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (335 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 3.46M 2026-11-16 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
dei EntityPublicFloat Entity Public Float USD 9.80M 2025-06-30 2025 FY 10-K 2026-03-26 0001193125-26-126278
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 960,054 2025-01-01 2025-12-31 DEF 14A 2026-07-31 0001193125-26-328604
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 952,574 2025-01-01 2025-12-31 DEF 14A 2026-07-31 0001193125-26-328604
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 1.28M 2025-01-01 2025-12-31 DEF 14A 2026-07-31 0001193125-26-328604
ecd PeoTotalCompAmt PeoTotalCompAmt USD 1.27M 2025-01-01 2025-12-31 DEF 14A 2026-07-31 0001193125-26-328604
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 0 2025-01-01 2025-12-31 DEF 14A 2026-07-31 0001193125-26-328604
ffd NetFeeAmt NetFeeAmt USD 604.17 2026-11-20 S-1 2026-11-20 0001193125-26-470268
ffd TtlFeeAmt TtlFeeAmt USD 604.17 2026-11-20 S-1 2026-11-20 0001193125-26-470268
ffd TtlOfferingAmt TtlOfferingAmt USD 6.94M 2026-11-20 S-1 2026-11-20 0001193125-26-470268
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-11-20 S-1 2026-11-20 0001193125-26-470268
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-11-20 S-1 2026-11-20 0001193125-26-470268
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 2.22M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-269598
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 1.48M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 7.02M 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 4.04M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 593,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 14.14M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -105,000 2017-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 301.36M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap AdjustmentForAmortization Amortization USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-24 0001564590-22-011575
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 51,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap AdjustmentsToAdditionalPaidInCapitalStockSplit Adjustments to Additional Paid in Capital, Stock Split USD -1,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 600,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001193125-26-350559
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap AllowanceForDoubtfulAccountsReceivableNoncurrent Accounts Receivable, Allowance for Credit Loss, Noncurrent USD 3.30M 2016-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 800,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 71.01M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap Assets Assets USD 13.36M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap AssetsCurrent Assets, Current USD 9.70M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 29.05M 2018-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperation Disposal Group, Including Discontinued Operation, Assets USD 23.77M 2019-12-31 2020 FY 10-K 2021-03-31 0001564590-21-016875
us-gaap AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Assets, Current USD 16.31M 2019-12-31 2020 FY 10-K 2021-03-31 0001564590-21-016875
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 73.69M 2017-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 500,000 2021-03-31 2021 FY 10-K 2022-03-24 0001564590-22-011575
us-gaap BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability USD -444,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap BusinessCombinationContingentConsiderationLiabilityCurrent Business Combination, Contingent Consideration, Liability, Current USD 444,000 2015-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap CapitalExpenditureDiscontinuedOperations Capital Expenditure, Discontinued Operations USD 0 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-13 0001564590-20-025066
us-gaap Cash Cash USD 1.63M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 8.27M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -2.58M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 25.33M 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-020870
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 8.27M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -13.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 6.65M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010757
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 491,403 2024-09-18 2025 Q1 10-Q 2025-05-15 0000950170-25-072622
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 6.06M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 2.67M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 2.67M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap CommonStockValue Common Stock, Value, Issued USD 115,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -40.45M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 19.93M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 5.01M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -12.05M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD -2,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD -710,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate pure 0.076 2018-02-22 2018-02-23 2018 Q1 10-Q 2018-05-10 0001564590-18-012733
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.23 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019685
us-gaap DeferredCostsCurrentAndNoncurrent Deferred Costs USD 1.10M 2021-03-31 2021 Q1 10-Q 2021-05-11 0001564590-21-026319
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -9.64M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap DeferredFinanceCostsGross Debt Issuance Costs, Gross USD 1.10M 2021-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019685
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -1.36M 2015-01-01 2015-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD 7.49M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-14 0001564590-18-029562
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -10.54M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 800,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 811,000 2016-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 2.90M 2016-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -902,000 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap DeferredTaxAssetParentsBasisInDiscontinuedOperation Deferred Tax Asset, Parent's Basis in Discontinued Operation USD 0 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 67,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 55.11M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 1.72M 2015-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 800,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 43.66M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 17.75M 2015-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 3.74M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 486,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 397,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsOther Deferred Tax Assets, Tax Credit Carryforwards, Other USD 797,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 3.46M 2015-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 12,000 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 54.31M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 2,000 2019-12-31 2020 FY 10-K 2021-03-31 0001564590-21-016875
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssets Deferred Tax Liabilities, Goodwill and Intangible Assets USD 13.04M 2015-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 15.82M 2016-06-30 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 575,000 2016-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 224,000 2017-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap DefinedBenefitPlanContributionsByEmployer Defined Benefit Plan, Plan Assets, Contributions by Employer USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent pure 0.06 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap Depreciation Depreciation USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 106,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax USD -1.58M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-24 0001564590-22-011575
us-gaap DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax USD 1.24M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-14 0000950170-25-020467
us-gaap DiscontinuedOperationTaxEffectOfDiscontinuedOperation Discontinued Operation, Tax Effect of Discontinued Operation USD 999,000 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-10 0001564590-20-053058
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net USD 7.02M 2019-12-31 2020 FY 10-K 2021-03-31 0001564590-21-016875
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities USD 878,000 2017-09-30 2017 Q3 10-Q 2017-11-13 0001564590-17-023382
us-gaap DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current USD 5.04M 2019-12-31 2020 FY 10-K 2021-03-31 0001564590-21-016875
us-gaap DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent Disposal Group, Including Discontinued Operation, Assets, Noncurrent USD 7.62M 2016-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent USD 4.42M 2019-12-31 2020 FY 10-K 2021-03-31 0001564590-21-016875
us-gaap DisposalGroupIncludingDiscontinuedOperationInventoryCurrent Disposal Group, Including Discontinued Operation, Inventory, Current USD 6.14M 2019-12-31 2020 FY 10-K 2021-03-31 0001564590-21-016875
us-gaap DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities Disposal Group, Including Discontinued Operation, Other Liabilities, Current USD 419,000 2019-12-31 2020 FY 10-K 2021-03-31 0001564590-21-016875
us-gaap DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current USD 3.15M 2019-12-31 2020 FY 10-K 2021-03-31 0001564590-21-016875
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD 9.65M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-14 0000950170-25-020467
us-gaap Dividends Dividends USD 2.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap DueFromOtherRelatedParties Due from Other Related Parties USD 20.00M 2016-08-04 2018 Q3 10-Q 2018-11-14 0001564590-18-029562
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -15.87 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -1.55 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019685
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -15.87 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.197 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap EffectiveIncomeTaxRateReconciliationDispositionOfBusiness Effective Income Tax Rate Reconciliation, Disposition of Business, Percent pure -0.079 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.001 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.033 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.025 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.008 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.048 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 1.45M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares Employee Stock Ownership Plan (ESOP), Number of Allocated Shares shares 84,900 2020-07-27 2020 FY 10-K 2021-03-31 0001564590-21-016875
us-gaap EscrowDeposit Escrow Deposit USD 750,000 2020-12-31 2021 FY 10-K 2022-03-24 0001564590-22-011575
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap FairValueAssetsLevel2ToLevel1TransfersAmount Fair Value, Assets, Level 2 to Level 1 Transfers, Amount USD 0 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 19,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD 463,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 444,000 2015-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 1,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-24 0001564590-22-011575
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 0 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001564590-22-037287
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 2,000 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001564590-22-037287
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 4.54M 2016-06-30 2016 Q2 10-Q/A 2016-09-22 0000950123-16-020493
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 830,000 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 830,000 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 830,000 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 830,000 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 20.81M 2016-06-30 2016 Q2 10-Q/A 2016-09-22 0000950123-16-020493
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 4.42M 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -47,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-05 0000950170-24-025428
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 14.34M 2020-01-01 2020-09-30 2020 Q3 10-Q 2020-11-10 0001564590-20-053058
us-gaap GainLossOnSaleOfBusiness Gain (Loss) on Disposition of Business USD 14.34M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-24 0001564590-22-011575
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 37.18M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-05 0000950170-24-025428
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 8.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap Goodwill Goodwill USD 29.21M 2016-06-30 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 41.80M 2016-01-01 2016-09-30 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 29.20M 2016-07-01 2016-09-30 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -25.97M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -25.97M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -19.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -1.59 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019685
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -87.38 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-14 0000950170-25-020467
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -87.38 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-14 0000950170-25-020467
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-14 0000950170-25-020467
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share USD/shares 0.04 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019685
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share USD/shares 164.87 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-14 0000950170-25-020467
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share USD/shares 164.87 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-14 0000950170-25-020467
us-gaap IncomeTaxCreditsAndAdjustments Income Tax Credits and Adjustments USD 400,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap IncomeTaxesPaid Income Taxes Paid USD 1.36M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap IncomeTaxesReceivable Income Taxes Receivable, Current USD 1.38M 2015-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 5.13M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -5.45M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 75,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 848,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 652,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 1.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 600,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -157,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 2.70M 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-10 0001564590-20-053058
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD -191,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD -3.71M 2017-01-01 2017-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -3.71M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -595,000 2016-01-01 2016-06-30 2016 Q2 10-Q/A 2016-09-22 0000950123-16-020493
us-gaap IncreaseDecreaseInIncomeTaxes Increase (Decrease) in Income Taxes USD 1.38M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 5.70M 2019-01-01 2019-09-30 2020 Q3 10-Q 2020-11-10 0001564590-20-053058
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD -1.51M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001564590-18-020781
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 10,000 2016-01-01 2016-06-30 2016 Q2 10-Q/A 2016-09-22 0000950123-16-020493
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -35,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap IncreaseDecreaseInRestrictedCashForOperatingActivities Increase (Decrease) in Restricted Cash for Operating Activities USD 400,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 1.78M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 1.93M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 3.69M 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap InventoryNet Inventory, Net USD 6.14M 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap InventoryRawMaterialsAndSuppliesNetOfReserves Inventory, Raw Materials and Supplies, Net of Reserves USD 491,000 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 1.96M 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap InventoryWriteDown Inventory Write-down USD 7.10M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 1.20M 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap LeaseCost Lease, Cost USD 890,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 5.96M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.38M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.40M 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041524
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.40M 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.38M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.38M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 418,000 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041524
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.33M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap Liabilities Liabilities USD 9.50M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 13.36M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap LiabilitiesCurrent Liabilities, Current USD 6.46M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent Disposal Group, Including Discontinued Operation, Liabilities, Current USD 8.13M 2019-12-31 2020 FY 10-K 2021-03-31 0001564590-21-016875
us-gaap LineOfCreditFacilityAnnualPrincipalPayment Line of Credit Facility, Annual Principal Payment USD 20.00M 2020-02-27 2020-02-28 2020 Q3 10-Q 2020-11-10 0001564590-20-053058
us-gaap LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity USD 25.00M 2020-08-05 2023 FY 10-K 2024-03-05 0000950170-24-025428
us-gaap LoansPayableCurrent Loans Payable, Current USD 19.71M 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041524
us-gaap LongTermDebt Long-term Debt USD 0 2023-12-31 2023 FY 10-K 2024-03-05 0000950170-24-025428
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 2.00M 2022-12-31 2023 FY 10-K 2024-03-05 0000950170-24-025428
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months USD 2.28M 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010757
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree Long-term Debt, Maturities, Repayments of Principal in Rolling Year Three USD 1.44M 2021-12-31 2021 FY 10-K 2022-03-24 0001564590-22-011575
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo Long-term Debt, Maturities, Repayments of Principal in Rolling Year Two USD 1.73M 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010757
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 1.46M 2022-12-31 2023 FY 10-K 2024-03-05 0000950170-24-025428
us-gaap LongTermLoansPayable Loans Payable, Noncurrent USD 2.36M 2022-06-30 2022 Q2 10-Q 2022-08-11 0001564590-22-029025
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 6.60M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 5.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -556,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012733
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -156,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 23.51M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012733
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -19.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -16.98M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012733
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -19.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -22.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -1.94M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap NumberOfReportingUnits Number of Reporting Units Unit 1 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-31 0001564590-21-016875
us-gaap OperatingExpenses Operating Expenses USD 14.90M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-14 0001564590-20-040295
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -19.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap OperatingLeaseCost Operating Lease, Cost USD 890,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 4.63M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 947,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 3.04M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 3.31M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 810,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 2.51M 2018-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 1.73M 2018-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 8,000 2018-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 103,000 2018-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 664,000 2018-12-31 2018 FY 10-K 2019-03-18 0001564590-19-008184
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 554,000 2016-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.12 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 205.90M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 702,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap OtherAssetsCurrent Other Assets, Current USD 967,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 68,000 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010757
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD 105,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 1.49M 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-269598
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2024-12-31 2024 FY 10-K 2025-02-14 0000950170-25-020467
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 28,000 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001564590-18-020781
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 1.59M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-14 0001564590-18-029562
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 292,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD -287,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap PaymentsForRoyalties Payments for Royalties USD 6.78M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-05 0000950170-24-025428
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 601,000 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041524
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 758,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 16.54M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 156,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 15.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.43M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 460,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 4.02M 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap ProceedsFromContributionsFromParent Proceeds from Contributions from Parent USD 71.22M 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap ProceedsFromDivestitureOfBusinesses Proceeds from Divestiture of Businesses USD 28.12M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-24 0001564590-22-011575
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 5.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 18.04M 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-13 0001564590-17-023382
us-gaap ProceedsFromIssuanceOfOtherLongTermDebt Proceeds from Issuance of Other Long-term Debt USD 24.73M 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-24 0001564590-22-011575
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 18,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 5.56M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap ProceedsFromRepaymentsOfRestrictedCashFinancingActivities Proceeds from (Repayments of) Restricted Cash, Financing Activities USD -10.00M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap ProceedsFromRoyaltiesReceived Proceeds from Royalties Received USD 33.90M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010757
us-gaap ProceedsFromSaleMaturityAndCollectionsOfInvestments Proceeds from Sale, Maturity and Collection of Investments USD 90.24M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 220,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010757
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 557,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -19.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 14.45M 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 353,000 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 200,000 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-31 0001564590-17-005738
us-gaap ReceivablesLongTermContractsOrPrograms Receivables, Long-term Contracts or Programs USD 3.66M 2021-12-31 2022 Q3 10-Q 2022-11-10 0001564590-22-037287
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 22.10M 2020-02-27 2020-02-28 2020 Q3 10-Q 2020-11-10 0001564590-20-053058
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-14 0000950170-25-020467
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 11.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap RestrictedCash Restricted Cash USD 1.26M 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010757
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 400,000 2018-06-30 2018 Q2 10-Q 2018-08-09 0001564590-18-020781
us-gaap RestrictedCashAndCashEquivalentsAtCarryingValue Restricted Cash and Cash Equivalents, Current USD 400,000 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 12.45M 2018-06-30 2018 Q2 10-Q 2018-08-09 0001564590-18-020781
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 1.26M 2021-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010757
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 7.50M 2019-12-31 2020 FY 10-K 2021-03-31 0001564590-21-016875
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -297.61M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 3.11M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-05 0000950170-24-025428
us-gaap RevenueFromRelatedParties Revenue from Related Parties USD 12.50M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-30 0000950170-23-010757
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 5.41M 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-10 0001564590-22-037287
us-gaap RoyaltyIncomeNonoperating Royalty Income, Nonoperating USD 2.50M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-05 0000950170-24-025428
us-gaap SalesRevenueGoodsNet Sales Revenue, Goods, Net (Deprecated 2018-01-31) USD 4.07M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012733
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 4.07M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-10 0001564590-18-012733
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 25.34M 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-25 0001564590-20-012791
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 166,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-14 0000950170-25-020467
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-269598
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 31,986 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019685
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2,731.66 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-14 0000950170-25-020467
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 0 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041524
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 1.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap SharePrice Share Price USD/shares 49.32 2025-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 58.5 2025-06-20 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap ShortTermInvestments Short-term Investments USD 9.19M 2018-09-30 2018 Q3 10-Q 2018-11-14 0001564590-18-029562
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 3.86M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap StockholdersEquityNoteSpinoffTransaction Stockholders' Equity Note, Spinoff Transaction USD 20,000 2016-01-01 2016-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.02 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 24.8 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0001564590-21-056494
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 4.32M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD -756,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD -2,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 25,000 2021-04-01 2021-06-30 2021 Q2 10-Q 2021-08-12 0001564590-21-043955
us-gaap UnamortizedDebtIssuanceExpense Unamortized Debt Issuance Expense USD 1.40M 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005384
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 5.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-26 0001193125-26-126278
us-gaap VariableLeaseCost Variable Lease, Cost USD 600,000 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0000950170-23-063379
us-gaap WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount WarrantDownRoundFeatureDecreaseInNetIncomeLossToCommonShareholderAmount USD 97,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 4.94M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-12 0001564590-22-019685
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 1.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001193125-26-462265

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →